Valensa International, a developer of nutraceuticals and functional food ingredients, has appointed Rudi Moerck as its new president and CEO. The move to add CEO duties for Dr Moerck comes on the heels of Valensa's partnership with Parry Nutraceuticals.
Subscribe to our email newsletter
In his new role, Dr Moerck will lead Valensa’s move into the next generation of high-performance plant-derived dietary supplements and functional food ingredients, which includes Valensa’s ‘direct to marketers’ product development and business strategy.
Dr Moerck will lead Valensa’s new management team that includes executives from both Valensa and Parry. Prior to joining Valensa, Dr Moerck was president of Altair Nanotechnologies.
Dr Moerck said: “We feel that our strategy at Valensa – to use the most scientifically important natural materials, to use the best technology and quality control, to optimize the product forms in terms of stability and efficacy, and to create compelling messages around our products – will position us as a ‘next generation’ leader to the industry and the consumer.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.